Measuring and Control Equipment Companies By Current Ratio

Current Ratio
Current RatioEfficiencyMarket RiskExp Return
1NAUT Nautilus Biotechnology
49.75
 0.03 
 5.86 
 0.18 
2QSI QuantumSi
35.44
 0.15 
 6.64 
 0.97 
3FCUV Focus Universal
23.35
(0.09)
 5.61 
(0.51)
4RPID Rapid Micro Biosystems
13.45
 0.15 
 5.00 
 0.76 
5ELSE Electro Sensors
11.68
 0.06 
 4.38 
 0.26 
6QTRX Quanterix Corp
11.27
 0.05 
 6.28 
 0.34 
7PACB Pacific Biosciences of
11.19
 0.08 
 5.49 
 0.43 
8EYPT Eyepoint Pharmaceuticals
6.16
 0.20 
 5.17 
 1.03 
9ONTO Onto Innovation
6.14
(0.02)
 4.75 
(0.10)
10OPXS Optex Systems Holdings,
5.97
 0.31 
 4.93 
 1.53 
11LAB Standard Biotools
5.87
 0.03 
 5.12 
 0.18 
12TXG 10X Genomics
5.65
 0.22 
 3.62 
 0.80 
13BIO Bio Rad Laboratories
5.5
 0.04 
 2.33 
 0.09 
14PRE Prenetics Global
5.05
 0.15 
 8.30 
 1.28 
15NVMI Nova
4.98
 0.26 
 3.04 
 0.80 
16GEOS Geospace Technologies
4.62
 0.13 
 10.66 
 1.39 
17HURC Hurco Companies
3.58
 0.18 
 3.09 
 0.56 
18BMI Badger Meter
3.2
 0.23 
 1.44 
 0.33 
19TER Teradyne
3.03
 0.21 
 2.40 
 0.50 
20ST Sensata Technologies Holding
2.98
 0.30 
 2.87 
 0.86 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company. Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).